FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:760-768 August 19, 2004 Number 8 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Goodman, J. L. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

ABSTRACT

Background Testing of blood donors for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United States as an investigational screening test in mid-1999 to identify donations made during the window period before seroconversion.

Methods We analyzed all antibody-nonreactive donations that were confirmed to be positive for HIV-1 and HCV RNA on nucleic acid–amplification testing of "minipools" (pools of 16 to 24 donations) by the main blood-collection programs in the United States during the first three years of nucleic acid screening.

Results Among 37,164,054 units screened, 12 were confirmed to be positive for HIV-1 RNA — or 1 in 3.1 million donations — only 2 of which were detected by HIV-1 p24 antigen testing. For HCV, of 39,721,404 units screened, 170 were confirmed to be positive for HCV RNA, or 1 in 230,000 donations (or 1 in 270,000 on the basis of 139 donations confirmed to be positive for HCV RNA with the use of a more sensitive HCV-antibody test). The respective rates of positive HCV and HIV-1 nucleic acid–amplification tests were 3.3 and 4.1 times as high among first-time donors as among donors who gave blood repeatedly. Follow-up studies of 67 HCV RNA–positive donors demonstrated that seroconversion occurred a median of 35 days after the index donation, followed by a low rate of resolution of viremia; three cases of long-term immunologically silent HCV infection were documented.

Conclusions Minipool nucleic acid–amplification testing has helped prevent the transmission of approximately 5 HIV-1 infections and 56 HCV infections annually and has reduced the residual risk of transfusion-transmitted HIV-1 and HCV to approximately 1 in 2 million blood units.

Source Information

From the American Red Cross, Gaithersburg, Md. (S.L.S.), and Rockville, Md. (R.Y.D.); Westat, Rockville, Md. (S.A.G., S.H.K., D.J.W.); the University of British Columbia, Victoria, B.C., Canada (S.H.K.); Puget Sound Blood Center, Seattle (D.M.S.); Blood Systems Laboratory, Tempe, Ariz. (S.C., M.P.B.); Blood Systems Research Institute, Blood Centers of the Pacific, San Francisco (M.P.B.); and the University of California, San Francisco (M.P.B.).

Address reprint requests to Dr. Stramer at the American Red Cross National Testing and Reference Laboratories, 9315 Gaither Rd., Gaithersburg, MD 20877, or at stramers{at}usa.redcross.org.

Full Text of this Article

Related Letters:

HIV-1 and HCV Infections among Antibody-Negative Blood Donors
Begovac J., Mihaljevic I., Perrin L., Laperche S., Pillonel J., Herve P., Prince A. M., Kainer M. A., Jarvis W. R., Stramer S. L., Dodd R. Y., Busch M. P., Goodman J. L.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:2232-2235, Nov 18, 2004. Correspondence

This article has been cited by other articles:

• Bharti, A. R., Letendre, S. L., Patra, K. P., Vinetz, J. M., Smith, D. M. (2009). Malaria Diagnosis by a Polymerase Chain Reaction-Based Assay Using a Pooling Strategy. Am J Trop Med Hyg 81: 754-757 [Abstract] [Full Text]  
• O'Neill, E., Richardson-Weber, L., McCormack, G., Uhl, L., Haspel, R. L. (2009). Strict Adherence to a Blood Bank Specimen Labeling Policy by All Clinical Laboratories Significantly Reduces the Incidence of "Wrong Blood in Tube". Am J Clin Pathol 132: 164-168 [Abstract] [Full Text]  
• Stevens, W. S., Noble, L., Berrie, L., Sarang, S., Scott, L. E. (2009). Ultra-High-Throughput, Automated Nucleic Acid Detection of Human Immunodeficiency Virus (HIV) for Infant Infection Diagnosis Using the Gen-Probe Aptima HIV-1 Screening Assay. J. Clin. Microbiol. 47: 2465-2469 [Abstract] [Full Text]  
• Ma, Z.-M., Stone, M., Piatak, M. Jr., Schweighardt, B., Haigwood, N. L., Montefiori, D., Lifson, J. D., Busch, M. P., Miller, C. J. (2009). High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection. J. Virol. 83: 3288-3297 [Abstract] [Full Text]  
• Hatano, H., Delwart, E. L., Norris, P. J., Lee, T.-H., Dunn-Williams, J., Hunt, P. W., Hoh, R., Stramer, S. L., Linnen, J. M., McCune, J. M., Martin, J. N., Busch, M. P., Deeks, S. G. (2009). Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy. J. Virol. 83: 329-335 [Abstract] [Full Text]  
• Owen, S. M., Yang, C., Spira, T., Ou, C. Y., Pau, C. P., Parekh, B. S., Candal, D., Kuehl, D., Kennedy, M. S., Rudolph, D., Luo, W., Delatorre, N., Masciotra, S., Kalish, M. L., Cowart, F., Barnett, T., Lal, R., McDougal, J. S. (2008). Alternative Algorithms for Human Immunodeficiency Virus Infection Diagnosis Using Tests That Are Licensed in the United States. J. Clin. Microbiol. 46: 1588-1595 [Abstract] [Full Text]  
• Adamson, J. W. (2008). New Blood, Old Blood, or No Blood?. NEJM 358: 1295-1296 [Full Text]  
• Page-Shafer, K., Pappalardo, B. L., Tobler, L. H., Phelps, B. H., Edlin, B. R., Moss, A. R., Wright, T. L., Wright, D. J., O'Brien, T. R., Caglioti, S., Busch, M. P. (2008). Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates. J. Clin. Microbiol. 46: 499-506 [Abstract] [Full Text]  
• Guan, M. (2007). Frequency, Causes, and New Challenges of Indeterminate Results in Western Blot Confirmatory Testing for Antibodies to Human Immunodeficiency Virus. CVI 14: 649-659 [Full Text]  
• Taylor, R. M., Fontana, R. J. (2007). Hepatitis C in Organ Donors and Heart Transplant Recipients. JAMA 297: 696-696 [Full Text]  
• Scott, J. D., Gretch, D. R. (2007). Molecular Diagnostics of Hepatitis C Virus Infection: A Systematic Review. JAMA 297: 724-732 [Abstract] [Full Text]  
• Klumpp, T. R., Siegel, D. L. (2007). Transfusion medicine. ASH-SAP 2007: 408-443 [Full Text]  
• JITTIWUTIKARN, J., THONGSAWAT, S., SURIYANON, V., MANEEKARN, N., CELENTANO, D., RAZAK, M. H., SRIRAK, N., VONGCHAK, T., KAWICHAI, S., THOMAS, D., SRIPAIPAN, T., NETSKI, D., ANANTHAKRISHNAN, A., NELSON, K. E. (2006). HEPATITIS C INFECTION AMONG DRUG USERS IN NORTHERN THAILAND. Am J Trop Med Hyg 74: 1111-1116 [Abstract] [Full Text]  
• Heyns, A. d. P., Benjamin, R. J., Swanevelder, J. P. R., Laycock, M. E., Pappalardo, B. L., Crookes, R. L., Wright, D. J., Busch, M. P. (2006). Prevalence of HIV-1 in Blood Donations Following Implementation of a Structured Blood Safety Policy in South Africa. JAMA 295: 519-526 [Abstract] [Full Text]  
• Kaufman, R. M. (2006). Platelets: Testing, Dosing and the Storage Lesion--Recent Advances. ASH Education Book 2006: 492-496 [Abstract] [Full Text]  
• Tugwell, B. D., Patel, P. R., Williams, I. T., Hedberg, K., Chai, F., Nainan, O. V., Thomas, A. R., Woll, J. E., Bell, B. P., Cieslak, P. R. (2005). Transmission of Hepatitis C Virus to Several Organ and Tissue Recipients from an Antibody-Negative Donor. ANN INTERN MED 143: 648-654 [Abstract] [Full Text]  
• Custer, B., Busch, M. P., Marfin, A. A., Petersen, L. R. (2005). The Cost-Effectiveness of Screening the U.S. Blood Supply for West Nile Virus. ANN INTERN MED 143: 486-492 [Abstract] [Full Text]  
• Padeh, Y. C., Rubinstein, A., Shliozberg, J. (2005). Common Variable Immunodeficiency and Testing for HIV-1. NEJM 353: 1074-1075 [Full Text]  
• Stramer, S. L., Fang, C. T., Foster, G. A., Wagner, A. G., Brodsky, J. P., Dodd, R. Y. (2005). West Nile Virus among Blood Donors in the United States, 2003 and 2004. NEJM 353: 451-459 [Abstract] [Full Text]  
• Busch, M. P., Caglioti, S., Robertson, E. F., McAuley, J. D., Tobler, L. H., Kamel, H., Linnen, J. M., Shyamala, V., Tomasulo, P., Kleinman, S. H. (2005). Screening the Blood Supply for West Nile Virus RNA by Nucleic Acid Amplification Testing. NEJM 353: 460-467 [Abstract] [Full Text]  
• Petersen, L. R., Epstein, J. S. (2005). Problem Solved? West Nile Virus and Transfusion Safety. NEJM 353: 516-517 [Full Text]  
• Laperche, S., Le Marrec, N., Girault, A., Bouchardeau, F., Servant-Delmas, A., Maniez-Montreuil, M., Gallian, P., Levayer, T., Morel, P., Simon, N. (2005). Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection. J. Clin. Microbiol. 43: 3877-3883 [Abstract] [Full Text]  
• Kotton, C. N., Fishman, J. A. (2005). Viral Infection in the Renal Transplant Recipient. J. Am. Soc. Nephrol. 16: 1758-1774 [Abstract] [Full Text]  
• Begovac, J., Mihaljevic, I., Perrin, L., Laperche, S., Pillonel, J., Herve, P., Prince, A. M., Kainer, M. A., Jarvis, W. R., Stramer, S. L., Dodd, R. Y., Busch, M. P., Goodman, J. L. (2004). HIV-1 and HCV Infections among Antibody-Negative Blood Donors. NEJM 351: 2232-2235 [Full Text]  
• (2004). New Level of HIV Testing for Blood and Tissue Donors. AIDS Clin Care 2004: 7-7 [Full Text]  
• (2004). Banked Blood and Tissue: Safer but Still Not Perfect. Journal Watch Cardiology 2004: 5-5 [Full Text]  
• (2004). Viral Infections from Blood Transfusions and Tissue Grafts: Reducing the Risk. JWatch Infect. Diseases 2004: 3-3 [Full Text]  
• (2004). Banked Blood and Tissue: Safer but Still Not Perfect. JWatch General 2004: 4-4 [Full Text]  
• Goodman, J. L. (2004). The Safety and Availability of Blood and Tissues -- Progress and Challenges. NEJM 351: 819-822 [Full Text]